EP2214697A4 - Nell-1-zusammensetzungen - Google Patents

Nell-1-zusammensetzungen

Info

Publication number
EP2214697A4
EP2214697A4 EP08844676A EP08844676A EP2214697A4 EP 2214697 A4 EP2214697 A4 EP 2214697A4 EP 08844676 A EP08844676 A EP 08844676A EP 08844676 A EP08844676 A EP 08844676A EP 2214697 A4 EP2214697 A4 EP 2214697A4
Authority
EP
European Patent Office
Prior art keywords
nell
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08844676A
Other languages
English (en)
French (fr)
Other versions
EP2214697A2 (de
Inventor
Kang Ting
Chia Soo
Xinli Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of EP2214697A2 publication Critical patent/EP2214697A2/de
Publication of EP2214697A4 publication Critical patent/EP2214697A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP08844676A 2007-10-30 2008-10-24 Nell-1-zusammensetzungen Withdrawn EP2214697A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98390307P 2007-10-30 2007-10-30
PCT/US2008/081168 WO2009058690A2 (en) 2007-10-30 2008-10-24 Nell-1 compositions

Publications (2)

Publication Number Publication Date
EP2214697A2 EP2214697A2 (de) 2010-08-11
EP2214697A4 true EP2214697A4 (de) 2011-05-18

Family

ID=40591716

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08844676A Withdrawn EP2214697A4 (de) 2007-10-30 2008-10-24 Nell-1-zusammensetzungen

Country Status (3)

Country Link
EP (1) EP2214697A4 (de)
CA (1) CA2704190A1 (de)
WO (1) WO2009058690A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010111421A2 (en) * 2009-03-25 2010-09-30 The Regents Of The University Of California Isoform nell-1 peptide
WO2019210080A1 (en) * 2018-04-25 2019-10-31 The Regents Of The University Of California Methods and compositions for skeletal and neurological disorders

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006089023A2 (en) * 2005-02-16 2006-08-24 The Regents Of The University Of California Pharmaceutical compositions for treating or preventing bone conditions
US20070134291A1 (en) * 1999-10-05 2007-06-14 Kang Ting Composition for cartilage

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2515208A1 (en) * 2003-02-07 2004-08-26 The Regents Of The University Of California Nell peptide expression systems and bone formation activity of nell peptide
US20060053503A1 (en) * 2004-07-30 2006-03-09 Ut-Battelle, Llc Cranial and vertebral defects associated with loss-of-function of Nell

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070134291A1 (en) * 1999-10-05 2007-06-14 Kang Ting Composition for cartilage
WO2006089023A2 (en) * 2005-02-16 2006-08-24 The Regents Of The University Of California Pharmaceutical compositions for treating or preventing bone conditions

Also Published As

Publication number Publication date
WO2009058690A2 (en) 2009-05-07
EP2214697A2 (de) 2010-08-11
WO2009058690A3 (en) 2009-09-24
CA2704190A1 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
EP2219637A4 (de) Avenanthramid enthaltende zusammensetzungen
IL199656A0 (en) Tablet-in-tablet compositions
GB0724342D0 (en) Anitbacterial compositions
HUE059171T2 (hu) Kompozíciók
GB0711683D0 (en) Compositions
GB0700534D0 (en) Composition
GB0722484D0 (en) Solid compositions
GB0712024D0 (en) Compositions
GB0714575D0 (en) Composition
GB0710888D0 (en) Composition
GB0713707D0 (en) Stable compositions
ZA201002504B (en) Novel taxoid-based compositions
GB0714569D0 (en) Composition
GB0705885D0 (en) Composition
GB0706343D0 (en) Composition
GB0702446D0 (en) Composition
GB0703719D0 (en) Composition
GB0706739D0 (en) Composition
GB0704651D0 (en) Composition
EP2214697A4 (de) Nell-1-zusammensetzungen
GB0707972D0 (en) Composition
GB0713976D0 (en) Composition
GB0710559D0 (en) Composition
GB0704659D0 (en) Composition
GB0706047D0 (en) Anit-viral compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100518

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20110418

17Q First examination report despatched

Effective date: 20130411

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20131022